Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(03): 214-218
DOI: 10.1055/s-0041-1729471
Original Article

Immature Platelet Fraction: Its Clinical Utility in Thrombocytopenia Patients

Garima Goel
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Shruti Semwal
2   Department of Pathology, L.N. Medical College and J.K. Hospital, Bhopal, Madhya Pradesh, India
,
Akriti Khare
3   Department of Hematology, All India Institute of Medical Sciences, Delhi, India
,
Deepti Joshi
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Chaitanya K. Amerneni
4   Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Abhijit Pakhare
5   Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Neelkamal Kapoor
1   Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Objectives Etiology of thrombocytopenia is multifactorial and its pathogenesis should be distinguished for appropriate management. Newly formed immature platelets are called reticulated platelets (RPs) and can be estimated in peripheral blood using automated hematology analyzers, which express them as immature platelet fraction (IPF). In the present study we intend to assess and establish the clinical utility of IPF in differentiating the two major causes of thrombocytopenia—decreased production and increased destruction of platelets—along with determining its significance in monitoring patients with thrombocytopenia.

Materials and Methods Sixty-one cases of thrombocytopenia and 101 healthy controls with normal platelet count were included in the study. IPF and all the other usual blood cell parameters were measured using a fully automated hematology analyzer. Based on the pathogenesis of thrombocytopenia, the cases were divided into groups and the difference in IPF value between the groups was evaluated.

Results The reference range of IPF among healthy controls was estimated to be 0.7 to 5.7%. The mean IPF was significantly higher in patients with increased peripheral destruction of platelets (13.4%) as compared to patients with decreased production of platelets (4.6%). The optimal cutoff value of IPF for differentiating patients with increased peripheral destruction of platelets from patients with decreased production of platelets was 5.95% with a sensitivity of 88% and specificity of 75.9%.

Conclusion Measurement of IPF is useful for detecting evidence of increased platelet production and helps in the initial evaluation of thrombocytopenia patients. It is a novel diagnostic method which can be used to differentiate patients with thrombocytopenia due to increased destruction of platelets from patients with thrombocytopenia due to bone marrow failure/suppression.

Keywords

thrombocytopenia - immature - platelet - fraction - reticulated


Publication History

Article published online:
15 June 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Naz A, Mukry SN, Shaikh MR, Bukhari AR, Shamsi TS. Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura. Pak J Med Sci 2016; 32 (03) 575-579
    PubMedGoogle Scholar
  • 2 Jung H, Jeon HK, Kim HJ, Kim SH. Immature platelet fraction: establishment of a reference interval and diagnostic measure for thrombocytopenia. Korean J Lab Med 2010; 30 (05) 451-459
    PubMedGoogle Scholar
  • 3 Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004; 126 (01) 93-99
    CrossrefPubMedGoogle Scholar
  • 4 Dadu T, Sehgal K, Joshi M, Khodaiji S. Evaluation of the immature platelet fraction as an indicator of platelet recovery in dengue patients. Int J Lab Hematol 2014; 36 (05) 499-504
    CrossrefPubMedGoogle Scholar
  • 5 Norfolk DR, Ancliffe PJ, Contreras M. et al Consensus conference on platelet transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. Br J Haematol 1998; 101 (04) 609-617
    CrossrefPubMedGoogle Scholar
  • 6 Buttarello M, Plebani M. Automated blood cell counts: state of the art. Am J Clin Pathol 2008; 130 (01) 104-116
    CrossrefPubMedGoogle Scholar
  • 7 Sachdev R, Tiwari AK, Goel S, Raina V, Sethi M. Establishing biological reference intervals for novel platelet parameters (immature platelet fraction, high immature platelet fraction, platelet distribution width, platelet large cell ratio, platelet-X, plateletcrit, and platelet distribution width) and their correlations among each other. Indian J Pathol Microbiol 2014; 57 (02) 231-235
    CrossrefPubMedGoogle Scholar
  • 8 Abe Y, Wada H, Tomatsu H. et al A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006; 118 (04) 463-469
    CrossrefPubMedGoogle Scholar
  • 9 Robinson MS, Mackie IJ, Khair K. et al Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. Br J Haematol 1998; 100 (02) 351-357
    CrossrefPubMedGoogle Scholar
  • 10 Pons I, Monteagudo M, Lucchetti G. et al Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol 2010; 85 (02) 158-163
    PubMedGoogle Scholar
  • 11 Koyama K, Katayama S, Muronoi T. et al. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PLoS ONE 2018; 13 (01) e0192064
    CrossrefPubMedGoogle Scholar
  • 12 Chuansumrit A, Apiwattanakul N, Sirachainan N, Paisooksantivatana K, Athipongarporn A, Tangbubpha N, Kadegasem P, Tangnararatchakit K, Yoksan S. The use of immature platelet fraction to predict time to platelet recovery in patients with dengue infection. Paediatr Int Child Health 2020; 40 (02) 124-128 doi: DOI: 10.1080/20469047.2019.1697574.
    CrossrefPubMedGoogle Scholar
  • 13 Sakuragi M, Hayashi S, Maruyama M. et al Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation. Int J Hematol 2018; 107 (03) 320-326
    CrossrefPubMedGoogle Scholar
  • 14 Adly AA, Ragab IA, Ismail EAR, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets 2015; 26 (07) 645-650
    CrossrefPubMedGoogle Scholar
  • 15 McDonnell A, Bride KL, Lim D, Paessler M, Witmer CM, Lambert MP. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: differentiating from bone marrow failure and predicting bleeding risk. Pediatr Blood Cancer 2018; 65 (02) e26812
    CrossrefPubMedGoogle Scholar
  • 16 Cho YG, Lee JH, Kim DS, Lee HS, Choi SI. Clinical usefulness of the simple technique to diagnose thrombocytopenia using immature platelet fraction. Korean J Lab Med 2007; 27 (01) 1-6
    PubMedGoogle Scholar
  • 17 Jeon K, Kim M, Lee J. et al Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine (Baltimore) 2020; 99 (07) e19096
    CrossrefPubMedGoogle Scholar